INS and Insulin resistance: The mechanism of Chelerythrine in retaining the benefits of improving insulin sensitivity while reducing adverse reactions of thiazolidinedione shows that chelerythrine is a very promising drug, which can selectively target PPAR γ to further develop the clinical treatment of insulin resistance (46).